CCCC compared with SLDB: revenue, margins and what each company keeps, and the suppliers and customers both name

CCCCC4 Therapeutics, Inc.

Mkt capRevenueRevenue

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

Compare

CCCCC4 Therapeutics, Inc.

SLDBSolid Biosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CCCC 6

MRKMerckcustomer

PFEPfizersupplier

BIIBBiogen MAcustomer

—Betta Pharmaunlistedcustomer

2 more · CCCC chain ›

Shared 0

No shared counterparties.

Only SLDB 7

—FA212unlistedsupplier

—ICS Maugeriunlistedsupplier

—University of Pennsylvaniaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

University of Washington

unlistedsupplier

3 more · SLDB chain ›

CCCCC4 Therapeutics, Inc.

3.36▲+1.77%· post 3.36

Mkt cap$414.6MRevenue$7MQ2 FY26Revenue$36MFY25

SLDBSolid Biosciences Inc.

6.20▼−2.97%· post 6.20

ClosedOct 30 '26

Mkt cap$664.8MRevenue—Revenue—

Compare

ClosedOct 30 '26

CCCCC4 Therapeutics, Inc.

SLDBSolid Biosciences Inc.

3.36▲+1.77%post 3.36

Price

6.20▼−2.97%post 6.20

$414.6M

Mkt cap

$664.8M

Q2 FY26$7M

Revenue

—

FY25$36M

Revenue

—

CCCC3.36▲+1.77%vsSLDB6.20▼−2.97%ClosedOct 30 '26